SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 162.12 |
| Enterprise Value ($M) | 50.65 |
| Book Value ($M) | 70.67 |
| Book Value / Share | 1.47 |
| Price / Book | 2.29 |
| NCAV ($M) | 62.48 |
| NCAV / Share | 1.30 |
| Price / NCAV | 2.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.69 |
| Return on Assets (ROA) | -0.60 |
| Return on Equity (ROE) | -0.79 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.93 |
| Current Ratio | 3.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 111.47 |
| Assets | 119.66 |
| Liabilities | 48.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -129.69 |
| Net Income | -123.46 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted Distributed | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -104.02 |
| Cash from Investing | -0.10 |
| Cash from Financing | 0.08 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Soleus Private Equity Fund I, L.P. | 8.10 | -7.56 | |
| 13G/A | Tang Capital Partners Lp | 5.30 | -19.21 | |
| 13G/A | Short Jay M Phd | 7.20 | 15.97 | |
| 13G/A | Acorn Bioventures, L.p. | 8.40 | 47.89 | |
| 13G | BlackRock Inc. | 6.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| jay and car UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 242,977 | 1,279,439 | 18.99 | |
| 919,807 | 4,041,435 | 22.76 | |
| 54,180 | 635,272 | 8.53 | |
| 107,600 | 154,654 | 69.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVDL – Avadel Pharmaceuticals plc | AVTE – Aerovate Therapeutics, Inc. |
| AXSM – Axsome Therapeutics, Inc. | BIOR – Biora Therapeutics, Inc. |
| BTMD – biote Corp. |
Financial data and stock pages provided by
Fintel.io